Discrepancy in lamellar body counts (LBCs) between the Sysmex XE-2100 and Sysmex XT-2000i instruments

Articles in the same Issue

1. Letters to the Editor
2. Missing agreement between the two IMMULITE^® PSA assays
3. “Cerebrovascular stressing”: dipyridamole-induced S100B elevation predicts ischemic cerebrovascular events
4. Discrepancy in lamellar body counts (LBCs) between the Sysmex XE-2100 and Sysmex XT-2000i instruments
5. Interphase fluorescent in situ hybridization detection of the 7q11.23 chromosomal inversion in a clinical laboratory: automated versus manual scoring
6. Adrenocorticotropic hormone stability in preanalytical phase depends on temperature and proteolytic enzyme inhibitor
7. The impact on costs and efficiency of reducing the number of collected tubes
8. Improved software on the Sysmex XE-5000 BF mode for counting leukocytes in cerebrospinal fluid
9. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 are significantly related to PAPP-A levels
10. Preliminary evaluation of complete blood cell count on Mindray BC-6800
11. Rational use of laboratory tests: albuminuria
12. Masthead
13. Masthead
14. Editorials
15. Fifty years of CCLM – invitation to join us for a reception in Milan
16. Personalized (laboratory) medicine: a bridge to the future
17. PSA, PCA3 and the phi losophy of prostate cancer management
18. Reviews
19. Gender medicine: a task for the third millennium
20. Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis
21. Harmonization in laboratory medicine: the complete picture
22. Opinion Papers
23. Glycemic control in the clinical management of diabetic patients
24. Time for a conceptual shift in assessment of internal quality control for whole blood or cell-based testing systems? An evaluation using platelet function and the PFA-100 as a case example
25. Guidelines and Recommendations
26. A position paper of the EFLM Committee on Education and Training and Working Group on Distance Education Programmes/E-Learning: developing an e-learning platform for the education of stakeholders in laboratory medicine
27. General Clinical Chemistry and Laboratory Medicine
28. A novel weighted cumulative delta-check method for highly sensitive detection of specimen mix-up in the clinical laboratory
29. Identification and quantification of hemoglobins in whole blood: the analytical and organizational aspects of Capillarys 2 Flex Piercing compared with agarose electrophoresis and HPLC methods
30. Determination of the fatty acid profile of neutral lipids, free fatty acids and phospholipids in human plasma
31. Urinary iodine concentrations of pregnant women in Ukraine
32. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis
33. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method
34. Target analyte quantification by isotope dilution LC-MS/MS directly referring to internal standard concentrations – validation for serum cortisol measurement
35. Reference Values and Biological Variations
36. Reference values and upper reference limits for 26 trace elements in the urine of adults living in Belgium
37. Biological variation and reference change values of common clinical chemistry and haematologic laboratory analytes in the elderly population
38. Indirect determination of pediatric blood count reference intervals
39. Cancer Diagnostics
40. Suitability of quality control materials for prostate-specific antigen (PSA) measurement: inter-method variability of common tumor marker control materials
41. Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis
42. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study
43. Infectious Diseases
44. Polymorphic mononuclear neutrophils CD64 index for diagnosis of sepsis in postoperative surgical patients and critically ill patients
45. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia